• 2198 Citations
  • 26 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kwang Ho In is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles
Lung Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Asthma Medicine & Life Sciences
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Ventilator-Induced Lung Injury Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Pleural Effusion Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2015

Research Output 1989 2019

  • 2198 Citations
  • 26 h-Index
  • 138 Article
  • 2 Comment/debate
  • 2 Letter
  • 1 Review article
1 Citation (Scopus)

Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: A prospective pilot study

Choi, S. I., Lee, S. H., Park, J-Y., Kim, K. A., Lee, E. J., Lee, S. Y. & In, K. H., 2019 Jan 1, In : OncoTargets and Therapy. 12, p. 1661-1669 9 p.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Natural Killer Cells
Prospective Studies
Lung Neoplasms
Lung Diseases

Comparing the different diagnostic criteria of Asthma-COPD overlap

the Korean Asthma Research Group & KOCOSS cohort, 2018 Jan 1, (Accepted/In press) In : Allergy: European Journal of Allergy and Clinical Immunology.

Research output: Contribution to journalArticle

Chronic Obstructive Pulmonary Disease
Asthma
2 Citations (Scopus)

Toll-like receptor expression in pulmonary sensory neurons in the bleomycin-induced fibrosis model

Jung, W. J., Lee, S. Y., Choi, S. I., Kim, B. K., Lee, E. J., In, K. H. & Lee, M-G., 2018 Mar 1, In : PLoS One. 13, 3, e0193117.

Research output: Contribution to journalArticle

sensory neurons
Toll-Like Receptors
Sensory Receptor Cells
fibrosis
Neurons
5 Citations (Scopus)

NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy

Chang, B., Park, M. J., Choi, S. I., In, K. H., Kim, C. H. & Lee, S. H., 2017 Sep 19, In : OncoTargets and Therapy. 10, p. 4625-4633 9 p.

Research output: Contribution to journalArticle

Platinum
Non-Small Cell Lung Carcinoma
Drug Therapy
Survival
Confidence Intervals
9 Citations (Scopus)

Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial

Park, C. K., Oh, I. J., Kim, K. S., Choi, Y. D., Jang, T. W., Kim, Y. S., Lee, K. H., Shin, K. C., Jung, C. Y., Yang, S. H., Ryu, J. S., Jang, S. H., Yoo, S. S., Yong, S. J., Lee, K. Y., In, K. H., Lee, M. K. & Kim, Y. C., 2017 Jul 1, In : Clinical Lung Cancer. 18, 4, p. e289-e296

Research output: Contribution to journalArticle

docetaxel
Pemetrexed
Non-Small Cell Lung Carcinoma
Cisplatin
Therapeutics